SSA
THRN

Schonfeld Strategic Advisors’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

Schonfeld Strategic Advisors’s Portfolio THRN Stock Details THRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-95,000
Closed -$822K – 2668
2021
Q3 		$822K Buy
+95,000
New +$775K 0.01% 1039

Other funds holding THRN

DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Teacher Retirement System of Texas
Teacher Retirement System of Texas Austin, Texas $24B AUM 29.51% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return

Schonfeld Strategic Advisors's THRN Position: Q4 2021 in Review

Schonfeld Strategic Advisors sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q4 2021, closing a stake of 95,000 shares — an estimated $822K sold.

Schonfeld Strategic Advisors first reported a position in THRN in Q3 2021 and held it in 1 quarter. The position peaked at $822K in Q3 2021. 52 funds tracked by Wall St. Rank hold THRN as of Q4 2021.

  • Schonfeld Strategic Advisors reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 95,000 Thorne Healthtech, Inc. Common Stock shares in Q4 2021, an estimated $822K.
  • Schonfeld Strategic Advisors first reported a position in Thorne Healthtech, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Schonfeld Strategic Advisors's Thorne Healthtech, Inc. Common Stock position peaked at $822K in Q3 2021.
  • 52 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q4 2021.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.